Gus R. Rosania

2.4k citations
68 papers · 1.9k indexed · 1 hit paper · h-index 22
Topics
Drug Transport and Resistance Mechanisms (17 papers)Computational Drug Discovery Methods (9 papers)Erythrocyte Function and Pathophysiology (7 papers)

In The Last Decade

Gus R. Rosania

67 papers receiving 1.9k citations

Hit Papers

L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers ...2021202620222024202150100150200

Peers

Gus R. Rosania
Comparison fields: 5 of 129
  • Molecular Biology 784
  • Oncology 287
  • Biomedical Engineering 225
  • Materials Chemistry 208
  • Epidemiology 206
Replace Martin K. Safo with:
Martin K. Safo United States
Patrick J. Loll United States
Alexander Hillisch Germany
Andreas Larsson Sweden
David J. Maloney United States
William D. Pennie United States
Sang M. Chung United States
Margaret Lee United States
Alexis A. Borisy United States
Philip A. Harris United States
Gus R. Rosania relative to Martin K. Safo United States Martin K. Safo's profile →
Citations per field
00.5×1.5×1.9×
Martin K. Safo · 1×
Citations per year

Countries citing papers authored by Gus R. Rosania

Since Specialization
Citations

This map shows the geographic impact of Gus R. Rosania's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gus R. Rosania with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gus R. Rosania more than expected).

Fields of papers citing papers by Gus R. Rosania

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gus R. Rosania. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gus R. Rosania. The network helps show where Gus R. Rosania may publish in the future.

Co-authorship network of co-authors of Gus R. Rosania

This figure shows the co-authorship network connecting the top 25 collaborators of Gus R. Rosania. A scholar is included among the top collaborators of Gus R. Rosania based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gus R. Rosania. Gus R. Rosania is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 0
4 4
5 3
6 14
7 11
8 7
9 16
10 29
11 16
12 4
13 42
14 78
15
Image-to-Structure Task by ChemReader.
1
16 7
17 54
18 11
19 17
20 31

About Gus R. Rosania

Gus R. Rosania is a scholar working on Pharmaceutical Science, Biophysics and Pharmacology, having authored 68 papers that have together received 1.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (17 papers), Computational Drug Discovery Methods (9 papers) and Erythrocyte Function and Pathophysiology (7 papers). The work is most often cited by research in Pharmacology (199 citations), Biophysics (121 citations) and Pharmaceutical Science (110 citations). Gus R. Rosania has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Kathleen A. Stringer, Xinyuan Zhang, Rahul K. Keswani, Kerby Shedden, Nan Zheng, Richard W. Horobin, Johannes Kornhuber, Stefan Trapp, Young‐Tae Chang and Kyoung Ah Min. Their work appears in journals such as Angewandte Chemie International Edition, ACS Nano and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026